Correlation Between Viridian Therapeutics and Krystal Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Viridian Therapeutics and Krystal Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viridian Therapeutics and Krystal Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Viridian Therapeutics and Krystal Biotech, you can compare the effects of market volatilities on Viridian Therapeutics and Krystal Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viridian Therapeutics with a short position of Krystal Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viridian Therapeutics and Krystal Biotech.

Diversification Opportunities for Viridian Therapeutics and Krystal Biotech

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Viridian and Krystal is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Viridian Therapeutics and Krystal Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Krystal Biotech and Viridian Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viridian Therapeutics are associated (or correlated) with Krystal Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Krystal Biotech has no effect on the direction of Viridian Therapeutics i.e., Viridian Therapeutics and Krystal Biotech go up and down completely randomly.

Pair Corralation between Viridian Therapeutics and Krystal Biotech

Given the investment horizon of 90 days Viridian Therapeutics is expected to under-perform the Krystal Biotech. In addition to that, Viridian Therapeutics is 1.29 times more volatile than Krystal Biotech. It trades about -0.19 of its total potential returns per unit of risk. Krystal Biotech is currently generating about 0.1 per unit of volatility. If you would invest  17,275  in Krystal Biotech on August 24, 2024 and sell it today you would earn a total of  954.00  from holding Krystal Biotech or generate 5.52% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Viridian Therapeutics  vs.  Krystal Biotech

 Performance 
       Timeline  
Viridian Therapeutics 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Viridian Therapeutics are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of very conflicting fundamental indicators, Viridian Therapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.
Krystal Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Krystal Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the firm private investors.

Viridian Therapeutics and Krystal Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Viridian Therapeutics and Krystal Biotech

The main advantage of trading using opposite Viridian Therapeutics and Krystal Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viridian Therapeutics position performs unexpectedly, Krystal Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Krystal Biotech will offset losses from the drop in Krystal Biotech's long position.
The idea behind Viridian Therapeutics and Krystal Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.

Other Complementary Tools

Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine